Vitamin D toxicity explained

Vitamin D toxicity
Field:Endocrinology, toxicology

Vitamin D toxicity, or hypervitaminosis D, is the toxic state of an excess of vitamin D. The normal range for blood concentration in adults is 20 to 50 nanograms per milliliter (ng/mL).

Signs and symptoms

An excess of vitamin D causes abnormally high blood concentrations of calcium, which can cause overcalcification of the bones, soft tissues, heart and kidneys. In addition, hypertension can result. Symptoms of vitamin D toxicity may include the following:

Symptoms of vitamin D toxicity appear several months after excessive doses of vitamin D are administered. In almost every case, a low-calcium diet combined with corticosteroid drugs will allow for a full recovery within a month. It is possible that some of the symptoms of vitamin D toxicity are actually due to vitamin K depletion. One animal experiment has demonstrated that co-consumption with vitamin K reduced adverse effects, but this has not been tested in humans.[1] However the interconnected relationships between vitamin A, vitamin D, and vitamin K, outlined in a 2007 paper[2] published in the journal Medical Hypotheses, describes potential feedback loops between these three vitamins that could be elucidated by future research.

A mutation of the CYP24A1 gene can lead to a reduction in the degradation of vitamin D and to hypercalcemia (see Vitamin D: Excess).

Recommended supplement limits

The U.S National Academy of Medicine has established a Tolerable Upper Intake Level (UL) to protect against vitamin D toxicity ("The UL is not intended as a target intake; rather, the risk for harm begins to increase once intakes surpass this level.").[3] These levels in microgram (mcg or μg) and International Units (IU) for both males and females, by age, are:
(Conversion : 1 μg = 40 IU and 0.025 μg = 1 IU.[4])

The recommended dietary allowance is 15 μg/d (600 IU per day; 800 IU for those over 70 years). Overdose has been observed at 1,925 μg/d (77,000 IU per day). Acute overdose requires between 15,000 μg/d (600,000 IU per day) and 42,000 μg/d (1,680,000 IU per day) over a period of several days to months.

Suggested tolerable upper intake level

Based on risk assessment, a safe upper intake level of 250 μg (10,000 IU) per day in healthy adults has been suggested by non-government authors.[5] [6] Blood levels of 25-hydroxyvitamin D necessary to cause adverse effects in adults are thought to be greater than about 150 ng/mL, leading the Endocrine Society to suggest an upper limit for safety of 100 ng/mL.[7]

Long-term effects of supplementary oral intake

Excessive exposure to sunlight poses no risk in vitamin D toxicity through overproduction of vitamin D precursor, cholecalciferol, regulating vitamin D production. During ultraviolet exposure, the concentration of vitamin D precursors produced in the skin reaches an equilibrium, and any further vitamin D that is produced is degraded.[8] This process is less efficient with increased melanin pigmentation in the skin. Endogenous production with full body exposure to sunlight is comparable to taking an oral dose between 250 μg and 625 μg (10,000 IU and 25,000 IU) per day.[9]

Vitamin D oral supplementation and skin synthesis have a different effect on the transport form of vitamin D, plasma calcifediol concentrations. Endogenously synthesized vitamin D3 travels mainly with vitamin D-binding protein (DBP), which slows hepatic delivery of vitamin D and the availability in the plasma.[10] In contrast, orally administered vitamin D produces rapid hepatic delivery of vitamin D and increases plasma calcifediol.[10]

It has been questioned whether to ascribe a state of sub-optimal vitamin D status when the annual variation in ultraviolet will naturally produce a period of falling levels, and such a seasonal decline has been a part of Europeans' adaptive environment for 1000 generations.[11] [12] Still more contentious is recommending supplementation when those supposedly in need of it are labeled healthy and serious doubts exist as to the long-term effect of attaining and maintaining serum 25(OH)D of at least 80 nmol/L by supplementation.[13]

Current theories of the mechanism behind vitamin D toxicity (starting at a plasmatic concentration of ≈750 nmol/L[14]) propose that:

All of these affect gene transcription and overwhelm the vitamin D signal transduction process, leading to vitamin D toxicity.[14]

Cardiovascular disease

Evidence suggests that dietary vitamin D may be carried by lipoprotein particles into cells of the artery wall and atherosclerotic plaque, where it may be converted to active form by monocyte-macrophages.[10] [15] [16] This raises questions regarding the effects of vitamin D intake on atherosclerotic calcification and cardiovascular risk as it may be causing vascular calcification.[17] Calcifediol is implicated in the etiology of atherosclerosis, especially in non-Whites.[18] [19]

The levels of the active form of vitamin D, calcitriol, are inversely correlated with coronary calcification.[20] Moreover, the active vitamin D analog, alfacalcidol, seems to protect patients from developing vascular calcification.[21] [22] Serum vitamin D has been found to correlate with calcified atherosclerotic plaque in African Americans as they have higher active serum vitamin D levels compared to Euro-Americans.[19] [23] [24] [25] Higher levels of calcidiol positively correlate with aorta and carotid calcified atherosclerotic plaque in African Americans but not with coronary plaque, whereas individuals of European descent have an opposite, negative association.[19] There are racial differences in the association of coronary calcified plaque in that there is less calcified atherosclerotic plaque in the coronary arteries of African-Americans than in whites.[26]

Among descent groups with heavy sun exposure during their evolution, taking supplemental vitamin D to attain the 25(OH)D level associated with optimal health in studies done with mainly European populations may have deleterious outcomes. Despite abundant sunshine in India, vitamin D status in Indians is low and suggests a public health need to fortify Indian foods with vitamin D. However, the levels found in India are consistent with many other studies of tropical populations which have found that even an extreme amount of sun exposure, does not raise 25(OH)D levels to the levels typically found in Europeans.[27] [28] [29] [30]

Recommendations stemming for a single standard for optimal serum 25(OH)D concentrations ignores the differing genetically mediated determinates of serum 25(OH)D and may result in ethnic minorities in Western countries having the results of studies done with subjects not representative of ethnic diversity applied to them. Vitamin D levels vary for genetically mediated reasons as well as environmental ones.[31] [32] [33] [34]

Ethnic differences

Possible ethnic differences in physiological pathways for ingested vitamin D, such as the Inuit, may confound across the board recommendations for vitamin D levels. Inuit compensate for lower production of vitamin D by converting more of this vitamin to its most active form.[35]

A Toronto study of young Canadians of diverse ancestry applied a standard of serum 25(OH)D levels that was significantly higher than official recommendations.[36] [37] These levels were described to be 75 nmol/L as "optimal", between 75 nmol/L and 50 nmol/L as "insufficient" and <50 nmol/L as "deficient". 22% of individuals of European ancestry had 25(OH)D levels less than the 40 nmol/L cutoff, comparable to the values observed in previous studies (40 nmol/L is 15 ng/mL). 78% of individuals of East Asian ancestry and 77% of individuals of South Asian ancestry had 25(OH)D concentrations lower than 40 nmol/L. The East Asians in the Toronto sample had low 25(OH)D levels when compared to whites. In a Chinese population at particular risk for esophageal cancer and with the high serum 25(OH)D concentrations have a significantly increased risk of the precursor lesion.[38]

Studies on the South Asian population uniformly point to low 25(OH)D levels, despite abundant sunshine.[39] Rural men around Delhi average 44 nmol/L. Healthy Indians seem to have low 25(OH)D levels which are not very different from healthy South Asians living in Canada. Measuring melanin content to assess skin pigmentation showed an inverse relationship with serum 25(OH)D.[36] The uniform occurrence of very low serum 25(OH)D in Indians living in India and Chinese in China does not support the hypothesis that the low levels seen in the more pigmented are due to lack of synthesis from the sun at higher latitudes.

Premature aging

Complex regulatory mechanisms control metabolism. Recent epidemiologic evidence suggests that there is a narrow range of vitamin D levels in which vascular function is optimized. Animal research suggests that both excess and deficiency of vitamin D appears to cause abnormal functioning and premature aging.[40] [41] [42] [43]

Comparative Toxicity: Use of Vitamin D in Rodenticides

Vitamin D compounds, specifically cholecalciferol (D3) and ergocalciferol (D2), are used in rodenticides due to their ability to induce hypercalcemia, a condition characterized by elevated calcium levels in the blood. This overdose leads to organ failure and is pharmacologically similar to vitamin D's toxic effects in humans.

Concentrations used in these rodenticides are several orders of magnitude higher than the maximum recommended human intake, with acute baits containing 3,000,000 IU/g for D3 and 4,000,000 IU/g for D2. This leads to hypercalcemia in the rodents and subsequent death several days after ingestion.[44] [45]

See also

Notes and References

  1. Elshama SS, et al . Comparison between the protective effects of vitamin K and vitamin A on the modulation of hypervitaminosis D3 short-term toxicity in adult albino rats . Turk J Med Sci . 46 . 2 . 524–38 . 2016 . 27511521 . 10.3906/sag-1411-6 . free .
  2. Vitamin D toxicity redefined: Vitamin K and the molecular mechanism. 17145139. 2007. Masterjohn. C.. Medical Hypotheses. 68. 5. 1026–34. 10.1016/j.mehy.2006.09.051.
  3. Ross . etal . The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know . J Clin Endocrinol Metab . 2010 . 96 . 1 . 53–58 . 10.1210/jc.2010-2704 . 21118827 . 3046611 .
  4. Web site: Dietary Reference Intakes Tables [Health Canada, 2005]]. July 21, 2011. dead. https://web.archive.org/web/20110721054856/http://dietarysupplementdatabase.usda.nih.gov/ingredient_calculator/help.php#q9. July 21, 2011.
  5. Hathcock JN, Shao A, Vieth R, Heaney R . January 2007 . Risk assessment for vitamin D . The American Journal of Clinical Nutrition . 85 . 1 . 6–18 . 10.1093/ajcn/85.1.6 . 17209171 . free.
  6. Vieth R . Vitamin D toxicity, policy, and science . Journal of Bone and Mineral Research . 22 . V64-8 . December 2007 . Suppl 2 . 18290725 . 10.1359/jbmr.07s221 . 24460808 . free .
  7. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM . 2011 . Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline . J Clin Endocrinol Metab . 96 . 7 . 1922. 10.1210/jc.2011-0385 . 21646368 . 13662494 . free .
  8. Holick MF . Environmental factors that influence the cutaneous production of vitamin D . The American Journal of Clinical Nutrition . 61 . 3 Suppl . 638S–645S . March 1995 . 7879731 . 10.1093/ajcn/61.3.638S . free .
  9. Effects Of Vitamin D and the Natural selection of skin color:how much vitamin D nutrition are we talking about http://www.direct-ms.org/pdf/VitDVieth/Vieth%20Anthropology%20vit%20D.pdf
  10. Haddad JG, Matsuoka LY, Hollis BW, Hu YZ, Wortsman J . Human plasma transport of vitamin D after its endogenous synthesis . The Journal of Clinical Investigation . 91 . 6 . 2552–5 . June 1993 . 8390483 . 443317 . 10.1172/JCI116492 .
  11. Kull M, Kallikorm R, Tamm A, Lember M . Seasonal variance of 25-(OH) vitamin D in the general population of Estonia, a Northern European country . BMC Public Health . 9 . 22 . January 2009 . 19152676 . 2632995 . 10.1186/1471-2458-9-22 . free .
  12. Hoffecker JF . Out of Africa: modern human origins special feature: the spread of modern humans in Europe . Proceedings of the National Academy of Sciences of the United States of America . 106 . 38 . 16040–5 . September 2009 . 19571003 . 2752585 . 10.1073/pnas.0903446106 . 2009PNAS..10616040H . 40485016 . free .
  13. Lisa . Tseng . 2003 . Controversies in Vitamin D Supplementation . Nutrition Bytes . 9 . 1 .
  14. Jones G . Pharmacokinetics of vitamin D toxicity . The American Journal of Clinical Nutrition . 88 . 2 . 582S–586S . August 2008 . 18689406 . 10.1093/ajcn/88.2.582s. free .
  15. Hsu JJ, Tintut Y, Demer LL . Vitamin D and osteogenic differentiation in the artery wall . Clinical Journal of the American Society of Nephrology . 3 . 5 . 1542–7 . September 2008 . 18562594 . 4571147 . 10.2215/CJN.01220308 .
  16. Speeckaert MM, Taes YE, De Buyzere ML, Christophe AB, Kaufman JM, Delanghe JR . Investigation of the potential association of vitamin D binding protein with lipoproteins . Annals of Clinical Biochemistry . 47 . Pt 2 . 143–50 . March 2010 . 20144976 . 10.1258/acb.2009.009018 . free .
  17. Demer LL, Tintut Y . Vascular calcification: pathobiology of a multifaceted disease . Circulation . 117 . 22 . 2938–48 . June 2008 . 18519861 . 4431628 . 10.1161/CIRCULATIONAHA.107.743161 .
  18. Fraser DR . The physiological economy of vitamin D . Lancet . 1 . 8331 . 969–72 . April 1983 . 6132277 . 10.1016/S0140-6736(83)92090-1 . 31392498 .
  19. Freedman BI, Wagenknecht LE, Hairston KG, Bowden DW, Carr JJ, Hightower RC, Gordon EJ, Xu J, Langefeld CD, Divers J . Vitamin d, adiposity, and calcified atherosclerotic plaque in african-americans . The Journal of Clinical Endocrinology and Metabolism . 95 . 3 . 1076–83 . March 2010 . 20061416 . 2841532 . 10.1210/jc.2009-1797 .
  20. Watson KE, Abrolat ML, Malone LL, Hoeg JM, Doherty T, Detrano R, Demer LL . Active serum vitamin D levels are inversely correlated with coronary calcification . Circulation . 96 . 6 . 1755–60 . September 1997 . 9323058 . 10.1161/01.cir.96.6.1755 . 25969870 .
  21. Brandi L . 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis . Danish Medical Bulletin . 55 . 4 . 186–210 . November 2008 . 19232159 .
  22. Ogawa T, Ishida H, Akamatsu M, Matsuda N, Fujiu A, Ito K, Ando Y, Nitta K . Relation of oral 1alpha-hydroxy vitamin D3 to the progression of aortic arch calcification in hemodialysis patients . Heart and Vessels . 25 . 1 . 1–6 . January 2010 . 20091391 . 10.1007/s00380-009-1151-4 . 10713786 .
  23. Bell NH, Greene A, Epstein S, Oexmann MJ, Shaw S, Shary J . Evidence for alteration of the vitamin D-endocrine system in blacks . The Journal of Clinical Investigation . 76 . 2 . 470–3 . August 1985 . 3839801 . 423843 . 10.1172/JCI111995 .
  24. Cosman F, Nieves J, Dempster D, Lindsay R . Vitamin D economy in blacks . Journal of Bone and Mineral Research . 22 . V34-8 . December 2007 . Suppl 2 . 18290719 . 10.1359/jbmr.07s220 . 5251285 . free .
  25. Dawson-Hughes B . Racial/ethnic considerations in making recommendations for vitamin D for adult and elderly men and women . The American Journal of Clinical Nutrition . 80 . 6 Suppl . 1763S–6S . December 2004 . 15585802 . 10.1093/ajcn/80.6.1763S . free .
  26. Tang W, Arnett DK, Province MA, Lewis CE, North K, Carr JJ, Pankow JS, Hopkins PN, Devereux RB, Wilk JB, Wagenknecht L . Racial differences in the association of coronary calcified plaque with left ventricular hypertrophy: the National Heart, Lung, and Blood Institute Family Heart Study and Hypertension Genetic Epidemiology Network . The American Journal of Cardiology . 97 . 10 . 1441–8 . May 2006 . 16679080 . 10.1016/j.amjcard.2005.11.076 .
  27. Goswami R, Kochupillai N, Gupta N, Goswami D, Singh N, Dudha A . Presence of 25(OH) D deficiency in a rural North Indian village despite abundant sunshine . The Journal of the Association of Physicians of India . 56 . 755–7 . October 2008 . 19263699 .
  28. Lips P . Worldwide status of vitamin D nutrition . The Journal of Steroid Biochemistry and Molecular Biology . 121 . 1–2 . 297–300 . July 2010 . 20197091 . 10.1016/j.jsbmb.2010.02.021 . 8795644 .
  29. Schoenmakers I, Goldberg GR, Prentice A . Abundant sunshine and vitamin D deficiency . The British Journal of Nutrition . 99 . 6 . 1171–3 . June 2008 . 18234141 . 10.1017/S0007114508898662 . 2758994.
  30. Hagenau T, Vest R, Gissel TN, Poulsen CS, Erlandsen M, Mosekilde L, Vestergaard P . Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis . Osteoporosis International . 20 . 1 . 133–40 . January 2009 . 18458986 . 10.1007/s00198-008-0626-y . 3150030 .
  31. Engelman CD, Fingerlin TE, Langefeld CD, Hicks PJ, Rich SS, Wagenknecht LE, Bowden DW, Norris JM . Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans . The Journal of Clinical Endocrinology and Metabolism . 93 . 9 . 3381–8 . September 2008 . 18593774 . 2567851 . 10.1210/jc.2007-2702 .
  32. Creemers PC, Du Toit ED, Kriel J . DBP (vitamin D binding protein) and BF (properdin factor B) allele distribution in Namibian San and Khoi and in other South African populations . Gene Geography . 9 . 3 . 185–9 . December 1995 . 8740896 .
  33. Lips P . Vitamin D status and nutrition in Europe and Asia . The Journal of Steroid Biochemistry and Molecular Biology . 103 . 3–5 . 620–5 . March 2007 . 17287117 . 10.1016/j.jsbmb.2006.12.076 . 21295091 .
  34. Borges CR, Rehder DS, Jarvis JW, Schaab MR, Oran PE, Nelson RW . Full-length characterization of proteins in human populations . Clinical Chemistry . 56 . 2 . 202–11 . February 2010 . 19926773 . 10.1373/clinchem.2009.134858 . 1407188 .
  35. Rejnmark L, Jørgensen ME, Pedersen MB, Hansen JC, Heickendorff L, Lauridsen AL, Mulvad G, Siggaard C, Skjoldborg H, Sørensen TB, Pedersen EB, Mosekilde L . Vitamin D insufficiency in Greenlanders on a westernized fare: ethnic differences in calcitropic hormones between Greenlanders and Danes . Calcified Tissue International . 74 . 3 . 255–63 . March 2004 . 14708040 . 10.1007/s00223-003-0110-9 . 2887272 .
  36. Gozdzik A, Barta JL, Wu H, Wagner D, Cole DE, Vieth R, Whiting S, Parra EJ . Low wintertime vitamin D levels in a sample of healthy young adults of diverse ancestry living in the Toronto area: associations with vitamin D intake and skin pigmentation . BMC Public Health . 8 . 336 . September 2008 . 18817578 . 10.1186/1471-2458-8-336 . 2576234 . free .
  37. Scientific Advisory Committee on Nutrition (2007) Update on Vitamin D Position Statement by the Scientific Advisory Committee on Nutrition 2007
  38. Abnet CC, Chen W, Dawsey SM, Wei WQ, Roth MJ, Liu B, Lu N, Taylor PR, Qiao YL . Serum 25(OH)-vitamin D concentration and risk of esophageal squamous dysplasia . Cancer Epidemiology, Biomarkers & Prevention . 16 . 9 . 1889–93 . September 2007 . 17855710 . 2812415 . 10.1158/1055-9965.EPI-07-0461 .
  39. Web site: Vitamin D Status in India – Its Implications and Remedial Measures . January 26, 2023 . psu.edu.
  40. Tuohimaa P . Vitamin D and aging . The Journal of Steroid Biochemistry and Molecular Biology . 114 . 1–2 . 78–84 . March 2009 . 19444937 . 10.1016/j.jsbmb.2008.12.020 . 40625040 .
  41. Keisala T, Minasyan A, Lou YR, Zou J, Kalueff AV, Pyykkö I, Tuohimaa P . Premature aging in vitamin D receptor mutant mice . The Journal of Steroid Biochemistry and Molecular Biology . 115 . 3–5 . 91–7 . July 2009 . 19500727 . 10.1016/j.jsbmb.2009.03.007 . 25790204 .
  42. Tuohimaa P, Keisala T, Minasyan A, Cachat J, Kalueff A . Vitamin D, nervous system and aging . Psychoneuroendocrinology . 34 . S278-86 . December 2009 . Suppl 1 . 19660871 . 10.1016/j.psyneuen.2009.07.003 . 17462970 .
  43. Lanske B, Razzaque MS . Vitamin D and aging: old concepts and new insights . The Journal of Nutritional Biochemistry . 18 . 12 . 771–7 . December 2007 . 17531460 . 2776629 . 10.1016/j.jnutbio.2007.02.002 .
  44. CHOLECALCIFEROL: A UNIQUE TOXICANT FOR RODENT CONTROL . Proceedings of the Eleventh Vertebrate Pest Conference (1984) . University of Nebraska Lincoln . March 1984 . Cholecalciferol is an acute (single-feeding) and/or chronic (multiple-feeding) rodenticide toxicant with unique activity for controlling commensal rodents including anticoagulant-resistant rats. Cholecalciferol differs from conventional acute rodenticides in that no bait shyness is associated with consumption and time to death is delayed, with first dead rodents appearing 3-4 days after treatment. . https://web.archive.org/web/20190827013804/https://digitalcommons.unl.edu/vpc11/22/ . August 27, 2019 . live .
  45. Rizor. Suzanne E. . Arjo. Wendy M. . Bulkin. Stephan . Nolte. Dale L. . Efficacy of Cholecalciferol Baits for Pocket Gopher Control and Possible Effects on Non-Target Rodents in Pacific Northwest Forests . Vertebrate Pest Conference (2006) . USDA . 0.15% cholecalciferol bait appears to have application for pocket gopher control.' Cholecalciferol can be a single high-dose toxicant or a cumulative multiple low-dose toxicant. . August 27, 2019 . https://web.archive.org/web/20120914083512/http://naldc.nal.usda.gov/download/39036/PDF . September 14, 2012 . live .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Vitamin D toxicity".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.